The RNAi lines of <i>AaERF1</i> show decreased disease resistance. by Xu Lu (378799)

Peripheral invariant NKT (iNKT) cells decreased in CHB patients. by Xiaotao Jiang (191589)

Pathogenic <i>Salmonella</i> decreases Axin 1 protein expression in host cells. by Yong-guo Zhang (172527)

Formation of skin papillomas is decreased in <i>Miz1ΔPOZ</i> mice. by Jan Hönnemann (172721)

Prednisolone-pretreatment decreases ICAM-1 related pro-inflammatory cell activation. by Patrick Paulus (318716)

Univariable and multivariable analyses (age-adjusted), concerning a selection of medicaments p < 0.1 and n ≥ 10. by P.G.J. ter Horst (21743830)

Suppression of Beclin-1 by shRNA decreases tumor growth <i>in vivo</i>. by Xing-guo Zhao (731536)

<i>Nf1</i> OPG mice exhibit decreased hole poking in response to a novel holeboard apparatus. by David F. Wozniak (78177)

Decreased Pax6 led to increased <i>Pcsk1n</i> expression. by Ting Liu (45625)

Knockdown of <i>CPT1A</i> inactivates most of fatty acid oxidation (FAO) and decreases cellular proliferation. by Cong-Hui Yao (2013793)

“…<p>(A) Isotopologue distribution pattern of citrate in BT549 cells with scrambled small interfering RNA (siRNA) (scrambled, black) or after <i>CPT1A</i> knockdown (KD, red). …”

<i>casy-1</i> mutants show decreased GABAergic synaptic transmission at the NMJ. by Shruti Thapliyal (4951993)

“…Representative traces of mIPSCs and summary data for frequency and amplitude are shown. The <i>casy-1</i> mutants showed a significant decrease in mIPSCs rate compared to WT <i>C</i>. …”

<i>Cadm1</i> KO mice exhibit decreased bone mineral density. by Shinya Nakamura (97647)

Loss of <i>Nf1</i> increases sleep fragmentation and decreases sleep depth. by Elizabeth B. Brown (4582978)

“…<p><b>(A-C)</b> Sleep traits of <i>nf1</i>^P1 mutants, heterozygotes, and their respective control. …”

Cardamonin induced apoptosis and decreased the MMP of ovarian cancer cells. by Peiguang Niu (17044532)

Annual treatment frequencies in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

“…Mean outpatient visits in the recurrence group decreased from 13.6 ± 3.0 to 11.9 ± 5.0, 8.1 ± 3.9, and 7.8 ± 3.2 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, p < 0.001). …”

Sost and Sclerostin Expression are Decreased and Wnt Signaling is Increased in DMP1-caPTHR1 Transgenic Mice. by Charles A. O'Brien (271071)

Annual treatment frequencies in all eyes. by Yasuyuki Sotani (20114144)

“…<p>The number of anti-VEGF treatments, STTA, MA-PC, PPV, and total treatments (mean ± SD) significantly decreased from 2.6 ± 1.6, 0.3 ± 0.8, 0.6 ± 0.8, 0.1 ± 0.3, and 3.7 ± 1.7 preoperatively to 0.8 ± 1.9, 0.0 ± 0.2, 0.3 ± 1.0, 0.0, and 1.2 ± 2.2; at year 2 to 0.7 ± 2.0, 0.1 ± 0.6, 0.0 ± 0.2, 0.0 ± 0.2, and 1.0 ± 2.1; and at year 3 to 0.9 ± 2.2, 0.0, 0.2 ± 1.0, 0.0 ± 0.2, and 1.1 ± 3.1 (Kruskal–Wallis test, P < 0.001; Dunn’s test, **P < 0.01). …”

<i>IR52a</i> females showed reduced copulation. by Zhe He (508742)

Decreased s.c. growth of CNDT 2.5 cells after systemic administration of DOPC liposome-conjugated siNRP-2. by Shaija Samuel (341436)

“…NRP-2-siRNA DOPC-treatment led to a significant decrease in tumor growth compared with cntr siRNA DOPC-treatment (264.4 mm³ vs. 751.3 mm³, respectively; *<i>p</i> = 0.01). …”

MALT1 inhibition in mDCs decreases cytokine production in zymosan-treated cells. by Celine Dumont (9327751)